Krop IE - Search Results

1

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.

Janiszewska M, Stein S, Metzger Filho O, Eng J, Kingston NL, Harper NW, Rye IH, Alečković M, Trinh A, Murphy KC, Marangoni E, Cristea S, Oakes B, Winer EP, Krop IE, Russnes HG, Spellman PT, Bucher E, Hu Z, Chin K, Gray JW, Michor F, Polyak K. Janiszewska M, et al. Among authors: krop ie. JCI Insight. 2021 Jun 8;6(11):e147617. doi: 10.1172/jci.insight.147617. JCI Insight. 2021. PMID: 33886505 Free PMC article.

2

A SAGE (serial analysis of gene expression) view of breast tumor progression.

Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K. Porter DA, et al. Among authors: krop ie. Cancer Res. 2001 Aug 1;61(15):5697-702. Cancer Res. 2001. PMID: 11479200

3

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.

Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K. Krop IE, et al. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. doi: 10.1073/pnas.171138398. Epub 2001 Jul 31. Proc Natl Acad Sci U S A. 2001. PMID: 11481438 Free PMC article.

4

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

Seth P, Krop I, Porter D, Polyak K. Seth P, et al. Oncogene. 2002 Jan 24;21(5):836-43. doi: 10.1038/sj.onc.1205113. Oncogene. 2002. PMID: 11850811

5

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.

Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, Nevanlinna H, Borg A, Gelman R, Barkardottir RB, Lindblom A, Polyak K. Krop I, et al. Cancer Res. 2003 May 1;63(9):2024-7. Cancer Res. 2003. PMID: 12727813

6

Ovarian suppression for breast cancer: an effective treatment in search of a home.

Krop IE, Winer EP. Krop IE, et al. J Clin Oncol. 2005 Sep 1;23(25):5869-72. doi: 10.1200/JCO.2005.06.002. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087947 No abstract available.

7

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. Krop I, et al. Cancer Res. 2005 Nov 1;65(21):9659-69. doi: 10.1158/0008-5472.CAN-05-1663. Cancer Res. 2005. PMID: 16266985

8

A putative role for psoriasin in breast tumor progression.

Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139

9

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M. Segara D, et al. Among authors: krop ie. J Surg Oncol. 2007 Nov 1;96(6):474-80. doi: 10.1002/jso.20856. J Surg Oncol. 2007. PMID: 17640031 Clinical Trial.

10

Ten years of HER2-directed therapy: still questions after all these years.

Krop IE, Winer EP. Krop IE, et al. Breast Cancer Res Treat. 2009 Jan;113(2):207-9. doi: 10.1007/s10549-008-0041-2. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463974 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters